Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06914440

1 development in the corpus

NCT06914440

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · PHASE 2 TRIAL

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no posted results; it describes a planned study of neoadjuvant SBRT plus chemotherapy and immunotherapy in HR+/HER2− breast cancer, currently recruiting 27 participants.

PreliminaryToripalimab NCT06914440 Xijing Hospital

Reported

Planned enrollment27

PhasePHASE2

Primary outcome measureTotal pathologic complete response (tpCR) r…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support